| Date | Time | Source | Headline | Symbol | Company |
| 09/15/2008 | 8:45AM | PR Newswire (US) | Forest Laboratories, Inc. Appoints Frank Murdolo, Vice President - Investor Relations | NYSE:FRX | Forest Road Acquisition Corp |
| 09/04/2008 | 1:16PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 09/04/2008 | 8:00AM | PR Newswire (US) | USPTO Office Action in the Reexamination of U.S. Patent No. 6,545,040 | NYSE:FRX | Forest Road Acquisition Corp |
| 09/03/2008 | 11:13AM | Marketwired | BellwetherReport.com Analyst Opinions on FRX, KSS, CPS and CAG | NYSE:FRX | Forest Road Acquisition Corp |
| 09/03/2008 | 2:00AM | PR Newswire (US) | Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive | NYSE:FRX | Forest Road Acquisition Corp |
| 08/19/2008 | 12:49PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/18/2008 | 11:03AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 12:05PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 12:03PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 12:02PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 12:01PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 11:59AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2008 | 11:58AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/08/2008 | 11:44AM | Edgar (US Regulatory) | Forest Laboratories Inc - Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/08/2008 | 6:01AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/04/2008 | 4:04PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/30/2008 | 1:30PM | PR Newswire (US) | New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation | NYSE:FRX | Forest Road Acquisition Corp |
| 07/24/2008 | 11:08AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/23/2008 | 9:58AM | Edgar (US Regulatory) | Forest Laboratories Inc - Confidential Treatment Order (CT ORDER) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/22/2008 | 4:08PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/22/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Ag | NYSE:FRX | Forest Road Acquisition Corp |
| 07/01/2008 | 1:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Proxy Statement (definitive) (DEF 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/30/2008 | 5:42PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 06/20/2008 | 5:26PM | Edgar (US Regulatory) | Forest Laboratories Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/19/2008 | 7:50AM | PR Newswire (US) | Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated S | NYSE:FRX | Forest Road Acquisition Corp |
| 06/02/2008 | 4:35PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/30/2008 | 12:28PM | Edgar (US Regulatory) | Forest Laboratories Inc - Annual Report (10-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 6:30PM | PR Newswire (US) | Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Result | NYSE:FRX | Forest Road Acquisition Corp |
| 05/20/2008 | 11:30AM | PR Newswire (US) | Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f | NYSE:FRX | |
| 05/16/2008 | 3:54PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | Forest Road Acquisition Corp |